Search Within

Dina Patel

Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (7)
  2. Gastrointestinal Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Biostatistics Service (4)
  5. Center for Pancreatic Cancer Research (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. Nancy Kemeny (7)
  2. Alexandra Gewirtz (4)
  3. Marinela Capanu (4)
  4. Michael D'Angelica (4)
  5. William Jarnagin (3)
  6. Yuman Fong (3)

More People

Years
  1. 2014 (1)
  2. 2013 (1)
  3. 2011 (2)
  4. 2010 (1)
  5. 2009 (2)
Publications
  1. Journal of Clinical Oncology (4)
  2. Annals of Surgical Oncology (1)
  3. Breast Journal (1)
  4. Cancer Chemotherapy and Pharmacology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Springer (2)
  3. Wiley Blackwell (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab
    Journal Article

    Cercek, A.; D'Angelica, M.; Power, D.; Capanu, M.; Gewirtz, A.; Patel, D.; Allen, P.; Fong, Y.; DeMatteo, R. P.; Jarnagin, W. R.; more...
    Annals of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases
    Journal Article

    Ang, C.; Jhaveri, K.; Patel, D.; Gewirtz, A.; Seidman, A.; Kemeny, N.
    Breast Journal (2013)

    Fulltext@MSK | Save
  • Is PET scan conversion from positive to negative a prognostic indicator for patients receiving therapy for unresectable liver metastases from colorectal carcinoma (CRC)?
    Meeting Abstract

    Maddox, G. J.; Chou, J. F.; Capanu, M.; Patel, D.; D'Angelica, M. I.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) in the treatment of breast cancer with liver metastases (BCLM) in patients (pts) who progressed after hormonal and systemic chemotherapy (CTx)
    Meeting Abstract

    Herran, L. A.; Jhaveri, K. L.; Seidman, A. D.; Patel, D.; Gewirtz, A. N.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion
    Meeting Abstract

    Power, D. G.; Capanu, M.; Patel, D.; Gewirtz, A.; Jarnagin, W. R.; Fong, Y.; D'Angelica, M. I.; DeMatteo, R. P.; Kemeny, N. E.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies
    Journal Article

    Tse, A. N.; Wu, N.; Patel, D.; Haviland, D.; Kemeny, N.
    Cancer Chemotherapy and Pharmacology (2009)

    Fulltext@MSK | Save
  • Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
    Journal Article

    Kemeny, N. E.; Huitzil-Melendez, F. D.; Capanu, M.; Paty, P. B.; Fong, Y.; Schwartz, L. H.; Jarnagin, W. R.; Patel, D.; D'Angelica, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save